Martin Dekker is Officer of Bellerophon Therapeutics, Inc.. Currently has a direct ownership of 17,666 shares of BLPH, which is worth approximately $706. The most recent transaction as insider was on Dec 09, 2022, when has been sold 7,834 shares (Common Stock) at a price of $0.93 per share, resulting in proceeds of $7,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K
0% 3M change
0% 12M change
Total Value Held $706

Martin Dekker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2022
SELL
Payment of exercise price or tax liability
$7,285 $0.93 p/Share
7,834 Reduced 30.72%
17,666 Common Stock
Dec 09 2022
BUY
Exercise of conversion of derivative security
-
25,500 Added 50.0%
25,500 Common Stock
MD

Martin Dekker

Officer
Warren, NJ

Track Institutional and Insider Activities on BLPH

Follow Bellerophon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLPH shares.

Notify only if

Insider Trading

Get notified when an Bellerophon Therapeutics, Inc. insider buys or sells BLPH shares.

Notify only if

News

Receive news related to Bellerophon Therapeutics, Inc.

Track Activities on BLPH